2.5750.39% ( +0.010 )
Delay Closed: Nov 16, 16:08:11Valuation
Current ValuationThe current P/E ratio is 14.64, within the reasonable range, cheaper than 42.91% of the time in the past 1 years, and the industry ranks 19/53, the industry Median 6.94.
14.64xP/E
HK$2.58Stock price
HK$0.18Earnings per share
14.64xP/E
Stock priceHK$2.58Earnings per shareHK$0.18
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 14.44x
- Typical range
- 13.05x–15.15x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 6.94x
010203040
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 6.94x
0x20x40x60x80x100x
| Name/Symbol | |||
|---|---|---|---|
01093HKCSPC PHARMA | 10.91x | 128.56% | HK$93.33B |
02196HKFOSUN PHARMA | 10.44x | 10.29% | HK$42.74B |
02096HKSIMCERE PHARMA | 14.97x | 31.93% | HK$27.09B |
00867HKCMS | 13.65x | 41.06% | HK$24.11B |
01513HKLIVZON PHARMA | 12.23x | 17.45% | HK$22.18B |
00512HKGRANDPHARMA | 13.89x | 45.32% | HK$15.41B |
02005HKSSY GROUP | 14.64x | 24.61% | HK$7.43B |
03613HKTONGRENTANGCM | 12.76x | 15.96% | HK$4.60B |
01666HKTONG REN TANG | 10.88x | 21.20% | HK$3.84B |
00719HKSHANDONG XINHUA | 13.45x | -- | HK$3.58B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
